11 Dec 2025
Precision without a scaffold - When, why and how to use DCB in de novo lesions
With the collaboration of the GulfWIN initiative
Anchorperson:
S. Al Shaikh
Spokesperson:
S. Samargandy
Summary
This session provided an in-depth examination of drug-coated balloon (DCB) use in de novo coronary lesions, emphasizing patient selection, lesion preparation, and procedural technique. Clinical evidence and real-world cases illustrated when and why DCBs represent a precise alternative to stenting, particularly in small vessels, high bleeding risk patients, and bifurcation lesions.
Learning Objectives
- To understand when and why DCB is a viable alternative to stenting in selected de novo coronary lesions
- To learn the essential steps for optimal DCB use, including patient selection, lesion preparation and procedure technique
- To apply clinical evidence and real-world case insights to make informed, individualised decisions in daily practice
